Letters, Testimony & Comments

February 20, 2007
Comments regarding the treatment of prescription drugs under the Medicaid Drug Rebate Program
February 16, 2007
The Biotechnology Industry Organization (BIO) welcomes this opportunity to comment on the success of the Prescription Drug User Fee Act (PDUFA) and the proposed enhancements for PDUFA IV. BIO represents more than 1,100 biotechnology companies,...
February 6, 2007
BIO's Comments on the Town Hall Meeting
February 1, 2007
HOUSE COMMITTEE ON ENERGY & ENVIRONMENTAL PROTECTION February 1, 2007 House Bill 1048 Relating to Genetically Modified Crops Chair Morita and members of the House Committee on Energy & Environmental Protection, I am Rick Tsujimura,...
February 1, 2007
RE: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 72 Reg. 1033 (January 9, 2007) Dear Ms. Harrison: The Biotechnology Industry Organization (BIO) provides this letter in response to USTR...
February 1, 2007
Survey Finds Private Sector Negotiations Provide Both Savings and Choice, Making Government Interference Unnecessary.
February 1, 2007
BIO testimony opposing Hawaii House Bill 1048 which proposes a ban on all plantings of plant-made pharmaceutical, including in the laboratory setting.
February 1, 2007
BIO's testimony before the Advisory Panel on Ambulatory Payment Classification Groups
January 22, 2007
Dear President Bush: Now that the new Congress is in session we wanted to transmit our official policy recommendations on biofuels research and development and commercialization. Herin please find a menu of policy options that has been approved...
December 18, 2006
Comments to agency's Proposed Rule regarding collection of and access to claims data under Medicare Part D.
December 13, 2006
BIO's presentation to MCAC
December 8, 2006
BIO's comments
November 22, 2006
BIO's comments to CMS including list of recommended journals to be added
November 16, 2006
BIO's letter to CMS Acting Administrator Leslie Norwalk